Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults
Clinical trial NCT04173819 · COMPLETED
Trial details
- NCT number
- NCT04173819
- Sponsor
- International AIDS Vaccine Initiative
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-25
- Primary completion
- 2023-09-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.